Det primære endepunkt var en CO- bekræftet afholdenhedsrate (CA) fra uge 13 til og med uge 24 i den dobbelt- blindede behandlingsperiode.
The primary study endpoint was the CO-confirmed continuous abstinence rate from week 13 through week 24 in the double-blind treatment phase.